In preclinical antigen‐specific immunotherapy models, Foxp3− CD4+ regulatory (Tr1) T cells have been shown to suppress CD8+ T cells during the development of autoimmunity.5, 18. This evidence concerns the gene CD8A and Autoimmunity.